Sentence examples for more aggressive cardiovascular from inspiring English sources

Public health initiatives could target unemployed persons for more aggressive cardiovascular screening and interventions aimed at reducing risk-taking behaviors.

The treatment of RA as a CHD equivalent has also been proposed to encourage more aggressive cardiovascular risk management [ 10– 10].

In addition to helping clinicians with inpatient prognostication, this finding raises important clinical questions about the possible need for more aggressive cardiovascular risk factor assessment and monitoring in dermatomyositis outpatients in order to prevent hospitalization and death related to CVD.

By increasing awareness of the importance of lipid screening in RA, we can translate our knowledge about the relationship between RA and cardiovascular disease into more aggressive cardiovascular risk management in clinical practice.

Rates of cardiovascular events (for example, acute myocardial infarction) [ 15- 17] are higher in RA and PsA populations, and these patients are recognized to need more aggressive cardiovascular risk factor management than the general population [ 18].

One might argue that even those diabetic patients in whom major amputation cannot be avoided might profit from improved treatment structures by achieving more distal major amputation levels, tighter glycemic control, and more aggressive cardiovascular risk management.

In this context, the observed larger number of prescribed medications in diabetic patients also might hint at more aggressive management of cardiovascular risk factors.

In this context the observed larger number of prescribed medications in diabetic patients also might be a hint for more aggressive management of cardiovascular risk factors, not only a marker of comorbidity.

An increase in prescription claims for select evidence-based drug therapies suggests that both providers and patients are moving toward more aggressive management of cardiovascular risk factors in diabetes.

Nevertheless, early identification of nonobstructive CAD with MDCT-CA in patients with diabetes is clinically important because it may lead to a more aggressive strategy of cardiovascular risk factor control and modification of clinical follow-up.

Given the significant public health and cost implications of cognitive decline and the incidence of dementia in aging populations around the world, future research to identify whether more aggressive treatment of cardiovascular risks such as hypertension, hypercholesterolemia, and obesity leads to improved brain health among older adults could pay significant public health dividends.